{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:06:04Z","timestamp":1776146764874,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008890","name":"University of Dundee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.carres.2026.109892","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:57:50Z","timestamp":1773421070000},"page":"109892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["2-Phenyl-2H-1,2,3-triazole-oxime: oral anti-hyperglycemic effect and in vitro DMPK properties"],"prefix":"10.1016","volume":"564","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2384-2692","authenticated-orcid":false,"given":"Mario Roberto","family":"Senger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Ferreira","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana Viegas","family":"Schirato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter C\u00e9sar G\u00f3es","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"de Mello Rezende Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al\u00eassa Muniz","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Tadeu Gomes","family":"Gonzaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"de Carvalho da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor Francisco","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floriano Paes","family":"Silva-Jr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carres.2026.109892_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118245","article-title":"Unveiling the medicinal diversity of benzoic acid containing molecules: insights on druggable targets for type 2 diabetes mellitus","volume":"128","author":"Rani","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.carres.2026.109892_bib2","series-title":"International Diabetes Federation","article-title":"The diabetes atlas","year":"2025"},{"issue":"10467","key":"10.1016\/j.carres.2026.109892_bib3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","year":"2024","journal-title":"Lancet"},{"issue":"9626","key":"10.1016\/j.carres.2026.109892_bib4","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(08)60768-0","article-title":"Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies","volume":"371","author":"Mazzone","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.carres.2026.109892_bib5","article-title":"Cardiovascular complications of diabetes: from microvascular to macrovascular pathways","volume":"15","author":"Zakir","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.carres.2026.109892_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1056-8727(01)00184-2","article-title":"Risk of macrovascular and microvascular complications in type 2 diabetes","volume":"16","author":"Nazimek-Siewniak","year":"2002","journal-title":"J. Diabet. Complicat."},{"issue":"1","key":"10.1016\/j.carres.2026.109892_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S2213-8587(13)70025-1","article-title":"Dysglycaemia, vasculopenia, and the chronic consequences of diabetes","volume":"1","author":"Gerstein","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"10.1016\/j.carres.2026.109892_bib8","article-title":"Glycemic control for type 2 diabetes mellitus patients: a systematic review","volume":"14","author":"Bin Rakhis","year":"2022","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.carres.2026.109892_bib9","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00044-019-02396-4","article-title":"Screening of 1,2-furanonaphthoquinones 1,2,3-1H-triazoles for glycosidases inhibitory activity and free radical scavenging potential: an insight in anticancer activity","volume":"28","author":"Dantas","year":"2019","journal-title":"Med. Chem. Res."},{"issue":"23","key":"10.1016\/j.carres.2026.109892_bib10","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1007\/s00018-020-03564-1","article-title":"A comprehensive overview of substrate specificity of glycoside hydrolases and transporters in the small intestine","volume":"77","author":"Elferink","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.carres.2026.109892_bib11","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1021\/jm901265h","article-title":"Synthesis, biological activity, and molecular modeling studies of 1 H-1,2,3-Triazole derivatives of carbohydrates as \u03b1-Glucosidases inhibitors","volume":"53","author":"Ferreira","year":"2010","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.carres.2026.109892_bib12","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/cbic.201200272","article-title":"Kinetics studies on the inhibition mechanism of pancreatic \u03b1\u2010Amylase by glycoconjugated 1 H \u20101,2,3\u2010triazoles: a new class of inhibitors with hypoglycemiant activity","volume":"13","author":"Senger","year":"2012","journal-title":"Chembiochem"},{"key":"10.1016\/j.carres.2026.109892_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108762","article-title":"Dual \u03b1-amylase and \u03b1-glucosidase inhibitors: recent progress from natural and synthetic resources","volume":"163","author":"Jha","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.carres.2026.109892_bib14","series-title":"StatPearls [Internet]","article-title":"Alpha glucosidase inhibitors","author":"Akmal","year":"2025"},{"issue":"20","key":"10.1016\/j.carres.2026.109892_bib15","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1039\/D3CS00032J","article-title":"Glycosidase-targeting small molecules for biological and therapeutic applications","volume":"52","author":"Kim","year":"2023","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.carres.2026.109892_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000327","article-title":"Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes","volume":"2","author":"DiNicolantonio","year":"2015","journal-title":"Open Heart"},{"issue":"6","key":"10.1016\/j.carres.2026.109892_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3021","article-title":"Global status of diabetes prevention and prospects for action: a consensus statement","volume":"34","author":"Ibrahim","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.carres.2026.109892_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ejmech.2013.12.039","article-title":"1-Phenyl-1H- and 2-phenyl-2H-1,2,3-triazol derivatives: design, synthesis and inhibitory effect on alpha-glycosidases","volume":"74","author":"Gonzaga","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.carres.2026.109892_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117876","article-title":"Targeting dihydroorotate dehydrogenase (DHODH) for host-directed therapy: discovery of a novel alkyne-based scaffold inhibitor effective against SARS-CoV-2","volume":"297","author":"Vaidergorn","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.carres.2026.109892_bib20","article-title":"Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID moonshot SARS-CoV-2 mpro lead inhibitor","author":"Griffen","year":"2025","journal-title":"bioRxiv. Preprint"},{"issue":"1","key":"10.1016\/j.carres.2026.109892_bib21","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1038\/s41467-022-33736-5","article-title":"Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs","volume":"13","author":"Green","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.carres.2026.109892_bib22","series-title":"Compostos Derivados De 1-fenil-1H E 2-fenil-2H-1,2,3-triaz\u00f3is, Composi\u00e7\u00e3o Farmac\u00eautica E M\u00e9todos De Tratamento. BR Patent BR1020140275118","author":"Senger","year":"2023"},{"issue":"4","key":"10.1016\/j.carres.2026.109892_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0008-6215(01)00323-8","article-title":"Biosynthetic studies on the \u03b1-glucosidase inhibitor acarbose: the chemical synthesis of dTDP-4-amino-4,6-dideoxy-\u03b1-d-glucose","volume":"337","author":"Bowers","year":"2002","journal-title":"Carbohydr. Res."},{"issue":"1","key":"10.1016\/j.carres.2026.109892_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S2213-8587(13)70107-4","article-title":"Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes?","volume":"2","author":"Ma","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.carres.2026.109892_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1475-2840-13-81","article-title":"On the potential of acarbose to reduce cardiovascular disease","volume":"13","author":"Standl","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.carres.2026.109892_bib26","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41467-022-31232-4","article-title":"Complete biosynthetic pathway to the antidiabetic drug acarbose","volume":"13","author":"Tsunoda","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.carres.2026.109892_bib27","first-page":"605","article-title":"Biosynthesis and regulatory mechanism of acarbose and its structural analogs: a review","volume":"38","author":"Wang","year":"2022","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"issue":"19\u201320","key":"10.1016\/j.carres.2026.109892_bib28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.drudis.2010.08.004","article-title":"Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation","volume":"15","author":"Abad-Zapatero","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.carres.2026.109892_bib29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/17460441.2021.1884065","article-title":"Ligand efficiency indices for effective drug discovery: a unifying vector formulation","volume":"16","author":"Abad-Zapatero","year":"2021","journal-title":"Expet Opin. Drug Discov."},{"issue":"770","key":"10.1016\/j.carres.2026.109892_bib30","doi-asserted-by":"crossref","first-page":"eadm8631","DOI":"10.1126\/scitranslmed.adm8631","article-title":"Cryptosporidium lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacy","volume":"16","author":"Caldwell","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"13","key":"10.1016\/j.carres.2026.109892_bib31","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.febslet.2007.04.035","article-title":"Evidence of native starch degradation with human small intestinal maltase\u2010glucoamylase (recombinant)","volume":"581","author":"Ao","year":"2007","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.carres.2026.109892_bib32","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jmb.2007.10.069","article-title":"Human intestinal maltase\u2013glucoamylase: crystal structure of the N-Terminal catalytic subunit and basis of inhibition and substrate specificity","volume":"375","author":"Sim","year":"2008","journal-title":"J. Mol. Biol."}],"container-title":["Carbohydrate Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008621526000819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008621526000819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:26:45Z","timestamp":1776144405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008621526000819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":32,"alternative-id":["S0008621526000819"],"URL":"https:\/\/doi.org\/10.1016\/j.carres.2026.109892","relation":{},"ISSN":["0008-6215"],"issn-type":[{"value":"0008-6215","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2-Phenyl-2H-1,2,3-triazole-oxime: oral anti-hyperglycemic effect and in vitro DMPK properties","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carres.2026.109892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109892"}}